10x Genomics SG&A Expenses 2018-2024 | TXG

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

10x Genomics sg&a expenses from 2018 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

10x Genomics sg&a expenses from 2018 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Related Stocks
Company Name	Market Cap
Tempus AI (TEM)	$8.5B
Inspire Medical Systems (INSP)	$5.3B
Hims & Hers Health (HIMS)	$5.1B
Privia Health (PRVA)	$2.5B
Enovis (ENOV)	$2.5B
IRhythm Technologies (IRTC)	$2.4B
Azenta (AZTA)	$2B
Omnicell (OMCL)	$2B
Clover Health Investments (CLOV)	$1.6B
Schrodinger (SDGR)	$1.4B
Phreesia (PHR)	$1.1B
Butterfly Network (BFLY)	$650M
Standard BioTools (LAB)	$562M
Talkspace (TALK)	$522M
Fulgent Genetics (FLGT)	$520M
Definitive Healthcare (DH)	$483M
Health Catalyst (HCAT)	$459M
TruBridge (TBRG)	$244M
Pulmonx (LUNG)	$237M
SOPHiA GENETICS SA (SOPH)	$214M
American Well (AMWL)	$122M
EUDA Health Holdings (EUDA)	$107M
P3 Health Partners (PIII)	$75M
HeartBeam (BEAT)	$67M
111 (YI)	$53M
CareCloud (CCLD)	$46M
Zepp Health (ZEPP)	$40M
SHL Telemedicine (SHLT)	$40M
Outset Medical (OM)	$39M
Movano (MOVE)	$20M